Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07372495Not ApplicableRecruiting

Cerclage Plus Progesterone vs Progesterone Alone in Twin Short Cervix

Role: lead

NCT07366359Not ApplicableRecruiting

PGE2 Followed by Oxytocin vs Oxytocin in Term PROM (POXY-PROM)

Role: lead

NCT04419961Not ApplicableUnknown

Sexual Dysfunction and an Educational Program to Improve the Quality of Sexual Function in Vietnamese Pregnant Women in First Trimester

Role: lead

NCT04602143Not ApplicableCompleted

Effect of Testosterone Pretreatment in POR

Role: collaborator

All 4 trials loaded